Sex-dependent VEGF expression underlies variations in human pluripotent stem cell to endothelial progenitor differentiation
DOI: 10.1038/s41598-019-53054-z
Authors: Lauren N. Randolph; Xiaoping Bao; Michael Oddo; Xiaojun Lance Lian
Step 1: iPSC/ESC maintainance
day 0 ~ 2
culture “adherent” human PSC in “LaSR medium” for “2” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| Y-27623 | 5.0e-6 | mol/l |
Step 2: Primitive streak 1
day 2 ~ 3
culture “adherent” human PSC in “LaSR medium” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| CHIR90021 | 6.0e-6 | mol/l |
Step 3: endothelial 1
day 3 ~ 6
culture “adherent” human PSC in “LaSR medium” for “3” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| VEGF | 1.0e-4 | g/l |
Ideally, “EPC” should express “CDH5”, “CD34” at the end of culture.